JAN 21, 2021 8:00 AM PST

Critical reagent characterization for regulated bioassays accelerated by Uncle

Sponsored by: Unchained Labs
Speakers

Abstract
Date:  January 21, 2021
Time: 8:00am (PST),  11:00am (EST),  5:00pm (CET)
 
Today, critical reagent characterization is a key component in the overall workflow to establish robust ligand binding assays (e.g., immunoassays) for supporting the discovery and development of new biotherapeutic drugs. At B2S Life Sciences we have incorporated the Unchained Labs Uncle instrument into our comprehensive workflow to augment our detailed characterization of critical reagents. Our webinar will present two case studies where the Uncle technology provided crucial data about structural characteristics, which heretofore were not attainable by commonly used characterization methodologies, that enabled timely decision-making and decreased resource utilization. One major benefit of the Uncle is its ability to generate this key information using < 10 μL of test sample.
 
The first case study compares the characterization of two enzymes, where a difference in primary sequence resulted in differential aggregation behavior. Uncle DLS and Tm/Tagg data enabled selection of the correct isozyme for use in a critical assay. In the second case study we used the Uncle in early-phase drug development as the investigative tool to aid candidate selection for a series of bioconjugates. Case studies will highlight dynamic light scattering (DLS) and protein melting/aggregation (Tm/Tagg) analyses in the context of broader workflows for protein characterization.
 
Learning Objectives
  • How Uncle can supplement or replace more traditional characterization workflows
  • How Tm/Tagg measurements can support candidate selection or critical reagent selection
  • How the Uncle can accelerate drug development to enable efficient decision-making that results in decreased resource utilization and cost savings
 
 
Webinars will be available for unlimited on-demand viewing after live event.

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
MAR 16, 2022 8:00 AM PDT
C.E. CREDITS
MAR 16, 2022 8:00 AM PDT
Date: March 16, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CET) Handling of potent and/or hazardous substances is commonplace in sev.....
JUN 29, 2022 8:00 AM PDT
JUN 29, 2022 8:00 AM PDT
Date: June 29, 2022 Time: 8:00am (PST), 11:00am (EST), 5:00pm (CEST) As of May 2022, there have been more than 500 million confirmed cases of COVID-19, including numerous variants. Additiona...
NOV 30, 2021 10:00 AM PST
C.E. CREDITS
NOV 30, 2021 10:00 AM PST
Date: November 30, 2021 Time: 10:00am (PDT), 1:00pm (EDT) The prevalence of thyroid disease worldwide has served as a catalyst for healthcare providers to study various tools and methods to...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
Loading Comments...
Show Resources